XAIX:NSD- (USD)

ETF | Others |

Last Closing

USD 35.13

Change

-0.01 (-0.03)%

Market Cap

USD 0.04B

Volume

0.01M
Analyst Rating

N/A

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2025-05-28 )

Largest Industry Peers for Others

Symbol Name Price(Change) Market Cap
IBIT iShares Bitcoin Trust

-0.80 (-1.32%)

USD 65.59B
QQQM Invesco NASDAQ 100 ETF

+0.43 (+0.20%)

USD 46.74B
JEPQ JPMorgan Nasdaq Equity Premium..

+0.11 (+0.21%)

USD 25.59B
ACWI iShares MSCI ACWI ETF

+0.45 (+0.36%)

USD 19.99B
CGABL The Carlyle Group Inc. 4.625% ..

-0.06 (-0.36%)

USD 16.14B
TSLL Direxion Shares ETF Trust - Di..

+0.14 (+0.88%)

USD 6.20B
TBIL Rbb Fund Inc - Us Treasury 3 M..

N/A

USD 5.83B
NVDL GraniteShares 1.5x Long NVDA D..

+3.36 (+6.42%)

USD 3.52B
USCL iShares Climate Conscious & Tr..

+0.22 (+0.31%)

USD 2.21B
ETHA iShares Ethereum Trust ETF

+0.25 (+1.26%)

USD 2.13B

ETFs Containing XAIX

N/A

Market Performance

  Market Performance vs. Industry/Classification (Others) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 5.05% 80% B- 74% C
Dividend Return N/A N/A N/A N/A N/A
Total Return 5.05% 80% B- 74% C
Trailing 12 Months  
Capital Gain N/A N/A N/A N/A N/A
Dividend Return N/A N/A N/A N/A N/A
Total Return N/A N/A N/A N/A N/A
Trailing 5 Years  
Capital Gain N/A N/A N/A N/A N/A
Dividend Return N/A N/A N/A N/A N/A
Total Return N/A N/A N/A N/A N/A
Average Annual (5 Year Horizon)  
Capital Gain N/A N/A N/A N/A N/A
Dividend Return N/A N/A N/A N/A N/A
Total Return N/A N/A N/A N/A N/A
Risk Return Profile  
Volatility (Standard Deviation) N/A N/A N/A N/A N/A
Risk Adjusted Return N/A N/A N/A N/A N/A
Market Capitalization 0.04B 52% F 26% F

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:

There is nothing we particularly like

What to not like:

There is nothing we particularly dislike